Heron Therapeutics reported $12.1M in Gross Profit on Sales for its first fiscal quarter of 2022.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Gross Profit On Sales Change
Alnylam Pharmaceuticals ALNY:US $ 177.63M 43.24M
Amarin AMRN:US $ 72.39M 41.46M
Ani Pharmaceuticals ANIP:US $ 30.21M 3.18M
Anika Therapeutics ANIK:US $ 21.8M 3.67M
Eisai 4523:JP Y 140163M 18587M
Emergent Biosolutions EBS:US $ 151.6M 358.7M
Endo International Ordinary Shares ENDP:US $ 472.5M 94.46M
Esperion Therapeutics ESPR:US $ 11.71M 1.38M
GlaxoSmithKline GSK:LN 6.14B 283M
Heron Therapeutics HRTX:US $ 12.1M 2.39M
Insmed INSM:US $ 40.92M 1.92M
JAZZ PHA JAZZ:US $ 698.44M 62.14M
Ligand Pharmaceuticals LGND:US $ 40.99M 19.5M
Merk MRK:US $ 10567M 873M
Nektar Therapeutics NKTR:US $ 19.51M 0.66M
Neurocrine Biosciences NBIX:US $ 306M 1.9M
Pacira Pharmaceuticals PCRX:US $ 121.92M 1.73M
Regeneron Pharmaceuticals REGN:US $ 2560.2M 1408.9M
Surmodics SRDX:US $ 21M 2.49M
Teva Pharmaceutical Industries TEVA:US $ 1802M 323M
Ultragenyx Pharmaceutical RARE:US $ 73.83M 6.04M
Veracyte VCYT:US $ 44.07M 0.38M
Vertex Pharmaceuticals VRTX:US $ 1851.7M 26.53M